Etoposide
Back to searchMolecule Structure
Scientific Name
Etoposide
Description of the Drug
Etoposide is a podophyllotoxin derivative used to treat testicular and small cell lung tumors.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00773
http://www.drugbank.ca/drugs/DB00773
Brand Name(s)
Etoposide, Toposar, Vepesid
Company Owner(s)
Fresenius Kabi Usa Llc, Mylan Laboratories Ltd, Corden Pharma Latina Spa, Hospira Inc, Watson Laboratories Inc, Teva Parenteral Medicines Inc, Accord Healthcare Inc, Pierre Fabre Medicament, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
DNA topoisomerase II | PROTEIN FAMILY | INHIBITOR | CHEMBL2094255 |
Clinical Trial(s)
Unichem Links
Atlas | etoposide | |||||||||
SureChEMBL | SCHEMBL4259 | |||||||||
PharmGKB | PA449552 | |||||||||
Human Metabolome Database | HMDB0014911 | |||||||||
DrugBank | DB00773 | |||||||||
PubChem: Thomson Pharma | 14886949 | 14935915 | ||||||||
PubChem | 36462 | |||||||||
LINCS | LSM-6348 | |||||||||
Nikkaji | J3.178J | |||||||||
PDBe | EVP | |||||||||
BindingDB | 50127140 | |||||||||
DrugCentral | 1112 | |||||||||
Brenda | 153455 | 774 | 229442 | 92457 | 229441 | 154445 | 147647 | 49045 | 98367 | 21602 |
Guide to Pharmacology | 6815 | |||||||||
rxnorm | TOPOSAR | ETOPOSIDE | ||||||||
PubChem: Drugs of the Future | 12013288 | |||||||||
KEGG Ligand | C01576 | |||||||||
ChEBI | 4911 | |||||||||
ZINC | ZINC000003938684 |